188 related articles for article (PubMed ID: 26137570)
1. Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata.
Blume-Peytavi U; Vogt A
EBioMedicine; 2015 Apr; 2(4):282-3. PubMed ID: 26137570
[No Abstract] [Full Text] [Related]
2. Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib.
Jabbari A; Dai Z; Xing L; Cerise JE; Ramot Y; Berkun Y; Sanchez GA; Goldbach-Mansky R; Christiano AM; Clynes R; Zlotogorski A
EBioMedicine; 2015 Apr; 2(4):351-5. PubMed ID: 26137574
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting Janus kinases to treat alopecia areata.
Divito SJ; Kupper TS
Nat Med; 2014 Sep; 20(9):989-90. PubMed ID: 25198048
[TBL] [Abstract][Full Text] [Related]
4. JAK Inhibitors for Treatment of Alopecia Areata.
Wang EHC; Sallee BN; Tejeda CI; Christiano AM
J Invest Dermatol; 2018 Sep; 138(9):1911-1916. PubMed ID: 30057345
[TBL] [Abstract][Full Text] [Related]
5. Janus kinase inhibitors in dermatology: A systematic review.
Shreberk-Hassidim R; Ramot Y; Zlotogorski A
J Am Acad Dermatol; 2017 Apr; 76(4):745-753.e19. PubMed ID: 28169015
[TBL] [Abstract][Full Text] [Related]
6. Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata.
Gordon SC; Abudu M; Zancanaro P; Ko JM; Rosmarin D
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):e156-e157. PubMed ID: 30520145
[No Abstract] [Full Text] [Related]
7. Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata.
Bayart CB; DeNiro KL; Brichta L; Craiglow BG; Sidbury R
J Am Acad Dermatol; 2017 Jul; 77(1):167-170. PubMed ID: 28619556
[No Abstract] [Full Text] [Related]
8. JAK inhibitors in dermatology: The promise of a new drug class.
Damsky W; King BA
J Am Acad Dermatol; 2017 Apr; 76(4):736-744. PubMed ID: 28139263
[TBL] [Abstract][Full Text] [Related]
9. Topical Janus kinase inhibitors: A review of applications in dermatology.
Hosking AM; Juhasz M; Mesinkovska NA
J Am Acad Dermatol; 2018 Sep; 79(3):535-544. PubMed ID: 29673776
[TBL] [Abstract][Full Text] [Related]
10. Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata.
Tavakolpour S
Scand J Immunol; 2016 May; 83(5):345-6. PubMed ID: 26939767
[No Abstract] [Full Text] [Related]
11. Janus kinase inhibitors: An innovative treatment for alopecia areata.
Park H; Yu DA; Kwon O
J Dermatol; 2019 Aug; 46(8):724-730. PubMed ID: 31237712
[TBL] [Abstract][Full Text] [Related]
12. Tofacitinib, an Oral Janus Kinase Inhibitor: Perspectives in Dermatology.
Kostovic K; Gulin SJ; Mokos ZB; Ceovic R
Curr Med Chem; 2017 May; 24(11):1158-1167. PubMed ID: 28088907
[TBL] [Abstract][Full Text] [Related]
13. Role of janus kinase inhibitors in the treatment of alopecia areata.
Triyangkulsri K; Suchonwanit P
Drug Des Devel Ther; 2018; 12():2323-2335. PubMed ID: 30100707
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune disease: Getting to the root of hair loss in alopecia.
Bray N
Nat Rev Drug Discov; 2014 Oct; 13(10):724-5. PubMed ID: 25233992
[No Abstract] [Full Text] [Related]
15. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.
Xing L; Dai Z; Jabbari A; Cerise JE; Higgins CA; Gong W; de Jong A; Harel S; DeStefano GM; Rothman L; Singh P; Petukhova L; Mackay-Wiggan J; Christiano AM; Clynes R
Nat Med; 2014 Sep; 20(9):1043-9. PubMed ID: 25129481
[TBL] [Abstract][Full Text] [Related]
16. New and Emerging Therapies for Alopecia Areata.
Pourang A; Mesinkovska NA
Drugs; 2020 May; 80(7):635-646. PubMed ID: 32323220
[TBL] [Abstract][Full Text] [Related]
17. JAK-STAT signaling pathway inhibition: a role for treatment of various dermatologic diseases.
Kahn J; Deverapalli SC; Rosmarin D
Semin Cutan Med Surg; 2018 Sep; 37(3):198-208. PubMed ID: 30215638
[TBL] [Abstract][Full Text] [Related]
18. The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review.
de Oliveira AB; Alpalhão M; Filipe P; Maia-Silva J
Dermatol Ther; 2019 Sep; 32(5):e13053. PubMed ID: 31381252
[TBL] [Abstract][Full Text] [Related]
19. [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
Ramot Y; Zlotogorski A
Harefuah; 2020 Jan; 159(1):38-42. PubMed ID: 31930807
[TBL] [Abstract][Full Text] [Related]
20. Janus kinase inhibitors for the use of alopecia areata: A promising therapeutic of the future.
Updyke KM
Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29124830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
